Prices delayed by at least 15 minutes | Print
NOVARTIS N (NOVN)
Open
83.79 CHF
Previous close
84.52 CHF
Trade high
85.53 CHF
Volume
3,719,061
Year high
94.52 CHF
Year low
79.21 CHF
Dividend yield
3.9%
Market capitalisation
174.83 bn CHF
P/E ratio
22.59
ISIN
CH0012005267
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Company profile
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.